TG Therapeutics TGTX Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's shares (basic)?
- TG Therapeutics (TGTX) reported shares (basic) of 144.4M in Q1 2026.
- How has TG Therapeutics's shares (basic) changed year-over-year?
- TG Therapeutics's shares (basic) decreased by 1.5% year-over-year, from 146.7M to 144.4M.
- What is the long-term trend for TG Therapeutics's shares (basic)?
- Over 4 years (2021 to 2025), TG Therapeutics's shares (basic) has grown at a 2.5% compound annual growth rate (CAGR), from 528.5M to 583.2M.
- What does shares (basic) mean?
- The average number of common shares held by investors during the period.
- How do you interpret shares (basic)?
- An increase suggests share issuance, which may dilute existing shareholders, while a decrease suggests share buybacks.
- How does shares (basic) compare across companies?
- Varies based on the company's history of capital raises and share repurchase programs.